Journal Home
Access this journal onSciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.
Search for

Volume 4, Issue 5, Page 5 (May 2009)


View previous. 8 of 37 View next.

PTU Discouraged For Children With Graves Disease

DOUG BRUNK

The Endocrine Society has endorsed a recommendation to curtail the use of propylthiouracil as a first-line agent in children with Graves disease.

PII: S1558-0164(09)70130-0


View previous. 8 of 37 View next.